Navidea Biopharmaceuticals will collaborate with the University of Alabama at Birmingham (UAB) on a clinical study that will assess the safety and activity of a radiolabeled, humanized monoclonal antibody from its RIGS (radio-immuno-guided ...
Novogen, a biotechnology company, has announced the filing of a family of provisional patents in the US covering anti-tropomyosin (ATM) drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ...
VBL Therapeutics has secured fast track status from the US Food and Drug Administration (FDA) for its lead oncology drug VB-111, for prolongation of survival in patients with Recurrent Glioblastoma Multiforme (rGBM). VB-111 was already ...
US-based BioMedical Enterprises (BME) has obtained the US Food and Drug Administration (FDA) clearance (K131640) for its upgraded HammerLock Nitinol intramedullary fixation system for hammertoe deformities. The patent-pending HammerLock ...
Theraclone Sciences has received notification from the Biomedical Advanced Research and Development Authority (BARDA) informing the company that their proposal, 'Broad-spectrum anti-influenza A M2e fully human monoclonal antibody TCN-032: ...
The US Food and Drug Administration (FDA) has approved Merck's Noxafil (posaconazole) 100 mg delayed-release tablets. The tablets are a new formulation with a loading dose of 300mg (three 100mg delayed-release tablets) twice daily on the ...
Electronic cigarettes are addictive and contain dangerous chemicals, including nicotine, Netherlands public health officials said. The National Institute for Public Health and the Environment, usually known by its Dutch acronym RIVM, said ...
Tags: E-Cigarettes, Health, Medicine
Baxter International has initiated a voluntary recall of one lot of Nitroglycerin in 5% Dextrose injection due to particulate matter found in one vial. If infused, particulate matter could lead to potential venous and/or arterial ...
Tags: Dextrose Injection, Medicine
India-based Gland Pharma has announced an agreement under which KKR, a global investment firm, will acquire a minority stake in the company for approximately $200m, including KKR’s acquisition of the entire stake held by Evolvence ...
Tags: Gland Pharma, Medicine
A new project, co-funded with EUR8.5m from the European Commission is underway to accelerate the development of new vaccines, drugs and microbicides to fight against many poverty-related diseases such as tuberculosis (TB), HIV, malaria, ...
Tags: Poverty Related Diseases, Medicine
Canada-based ImStar Therapeutics has announced the selection of IMS-088 as its lead drug candidate for the treatment of amyotrophic lateral sclerosis. IMS-088 is a novel, small-molecule drug that stems from the discovery of a new target ...
Agalimmune, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours. The new company has been founded by an investment group comprising Loxbridge ...
Tags: solid tumours, cancer treatment
The European Medicines Agency (EMA) has fully validated and granted accelerated assessment to Boehringer Ingelheim's application for European marketing authorization of faldaprevir, a potent second generation oral protease inhibitor. ...
Prostate cancer stem cells evolve into different cells as the disease progresses and this becomes a moving target for treatment, U.S. researchers say. Drs. Andrew Goldstein, Owen Witte and Tanya Stoyanova and colleagues at the University ...
Tags: prostate cancer, stem cell, evolve, change, treatment, harder
Editas Medicine, a transformative genome editing company, today announced it has secured a $43m Series A financing led by Flagship Ventures, Polaris Partners and Third Rock Ventures with participation from Partners Innovation Fund. ...
Tags: Editas Medicine, genome editing